Gene · 3161
Papers2,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SARS-CoV-2 infection of phagocytic immune cells and COVID-19 pathology: Antibody-dependent as well as independent cell entry. | Front Immunol | 2022 | 36532011 | PubTator, text mining | PubMed |
| Potential biomarkers for active renal involvement in systemic lupus erythematosus patients. | Front Med (Lausanne) | 2022 | 36530895 | PubTator, text mining | PubMed |
| "RHAMM knockout" mice express a truncated RHAMM protein that promotes pancreatic cancer progression with dysfunctional p53. | Ann Pancreat Cancer | 2022 | 36507054 | PubTator, text mining | PubMed |
| Increased tumor glycolysis is associated with decreased immune infiltration across human solid tumors. | Front Immunol | 2022 | 36505421 | PubTator, text mining | PubMed |
| In Vitro Transcriptome Analysis of Cobalt Boride Nanoparticles on Human Pulmonary Alveolar Cells. | Materials (Basel) | 2022 | 36500178 | PubTator, text mining | PubMed |
| Identification of Novel Hub Genes Associated with Psoriasis Using Integrated Bioinformatics Analysis. | Int J Mol Sci | 2022 | 36499614 | PubTator, text mining | PubMed |
| Identification of a Small Molecule Inhibitor of Hyaluronan Synthesis, DDIT, Targeting Breast Cancer Cells. | Cancers (Basel) | 2022 | 36497283 | PubTator, text mining | PubMed |
| Reduced MHC Class I and II Expression in HPV-Negative vs. HPV-Positive Cervical Cancers. | Cells | 2022 | 36497170 | PubTator, text mining | PubMed |
| 4-Methylumebelliferone Enhances Radiosensitizing Effects of Radioresistant Oral Squamous Cell Carcinoma Cells via Hyaluronan Synthase 3 Suppression. | Cells | 2022 | 36497040 | PubTator, text mining | PubMed |
| CD5L-associated gene analyses highlight the dysregulations, prognostic effects, immune associations, and drug-sensitivity predicative potentials of LCAT and CDC20 in hepatocellular carcinoma. | Cancer Cell Int | 2022 | 36494696 | PubTator, text mining | PubMed |
| Construction and validation of prognostic signature for hepatocellular carcinoma basing on hepatitis B virus related specific genes. | Infect Agent Cancer | 2022 | 36474267 | PubTator, text mining | PubMed |
| Aggressive, early resistant and relapsed mantle cell lymphoma distinct extrinsic microenvironment highlighted by transcriptome analysis. | EJHaem | 2022 | 36467789 | PubTator, text mining | PubMed |
| Establishment of lung adenocarcinoma classification and risk model based on necroptosis-related genes. | Front Genet | 2022 | 36452156 | PubTator, text mining | PubMed |
| Plasmablastic Lymphoma in an Immunocompetent Patient: A Case Report and Literature Review. | Cureus | 2022 | 36447697 | PubTator, text mining | PubMed |
| Low-dose IL-2 reduces IL-21+ T cell frequency and induces anti-inflammatory gene expression in type 1 diabetes. | Nat Commun | 2022 | 36443294 | PubTator, text mining | PubMed |
| Human Umbilical Vein Endothelial Cells Form a Network on a Hyaluronic Acid/Gelatin Composite Hydrogel Moderately Crosslinked and Degraded by Hydrogen Peroxide. | Polymers (Basel) | 2022 | 36433161 | PubTator, text mining | PubMed |
| The Alterations and Roles of Glycosaminoglycans in Human Diseases. | Polymers (Basel) | 2022 | 36433141 | PubTator, text mining | PubMed |
| Ovarian Cancer-Cell Pericellular Hyaluronan Deposition Negatively Impacts Prognosis of Ovarian Cancer Patients. | Biomedicines | 2022 | 36428513 | PubTator, text mining | PubMed |
| Microcurrent and Gold Nanoparticles Combined with Hyaluronic Acid Accelerates Wound Healing. | Antioxidants (Basel) | 2022 | 36421443 | PubTator, text mining | PubMed |
| KIAA1199 Correlates With Tumor Microenvironment and Immune Infiltration in Lung Adenocarcinoma as a Potential Prognostic Biomarker. | Pathol Oncol Res | 2022 | 36419650 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3161/papers?page=20